switzerlanden
Emerging markets: the value of strategic allocation

Emerging markets: the value of strategic allocation

12-11-2015 | Research

The added value of allocating to emerging markets (EM) has always been a topic of discussion among equity investors, especially when there was a large difference in performance with developed markets (DM). After a period of market decline, investors sometimes consider to lower the weight of emerging markets in their portfolio. What are the lessons that history can teach us?

  • Weili  Zhou
    Weili
    Zhou
    Head of Quant Equity Research
  • Wilma de Groot, PhD
    Wilma
    de Groot, PhD
    Head of Core Quant Equities and Co-head of the Quant Equity Portfolio Management team

Speed read

  • Allocating to emerging stocks increases the Sharpe ratio of an equity/bond portfolio
  • Allocating to factors in emerging equity markets is even better
  • Dynamic allocation does not appear to add value: we recommend a strategic allocation

In investing it is always important to take the long view. In a recent paper with data over the period from January 1988 to September 2015, we have taken a fresh look at the strategic allocation to emerging equities.

We started by investigating the long-term return characteristics of developed markets equities as measured by the MSCI World index and emerging markets equities as measured by the MSCI Emerging Markets index. The excess returns over cash of emerging markets have been roughly 75% higher than in developed markets. The volatility is 50% higher, which, when combined, results in a higher Sharpe ratio.

We also found that allocating to emerging markets increases the risk-adjusted performance of a traditional developed markets equity/bond portfolio. The portfolio volatility increases when you add emerging equity markets. But returns are even higher, from 3.7% excess return when you do not allocate to emerging markets to 4.6% excess return when you allocate 20%, resulting in a significantly higher Sharpe ratio (up from 0.38 to 0.43).

Given the potential for extra returns investors might be tempted to dynamically allocate to emerging and developed market equities. We tested the predictive power of many factors and find little to no predictive power. Only for price momentum did we find some evidence in predicting whether emerging markets will out- or underperform developed markets. If momentum works, you could argue that this implies that the weights of emerging and developed market equities in portfolio should not be rebalanced too often.

Stay informed on Quant investing with monthly mail updates
Stay informed on Quant investing with monthly mail updates
Subscribe

Factor premiums in emerging markets

Investors can not only allocate to the emerging market equity premium, but also to other premiums within the equity market. We constructed a value and momentum index by each month considering the equally-weighted returns of the 33% most attractive stocks on respectively the earnings-to-price ratio and its 12-1 month momentum, assuming a 6-month holding period.

An emerging markets multi-factor quant portfolio consisting of a 50/50% allocation to the momentum and value factor premiums exhibits a significantly better risk-adjusted performance than the passive market portfolio. Specifically, the total return is over 6% higher than the market portfolio with similar volatility. The Sharpe ratio is 0.57 against 0.30 for the market index.

Emerging equity markets have disappointed in recent years. Yet, our empirical research shows that allocating part of an investor’s portfolio to emerging markets equity adds value and even more when the portfolio has exposures to the value and momentum factors. We therefore recommend investors to strategically allocate part of their portfolio to factor premiums in emerging equity markets.

Logo

Disclaimer Robeco Switzerland Ltd.

The information contained on these pages is for marketing purposes and solely intended for Qualified Investors in accordance with the Swiss Collective Investment Schemes Act of 23 June 2006 (“CISA”) domiciled in Switzerland, Professional Clients in accordance with Annex II of the Markets in Financial Instruments Directive II (“MiFID II”) domiciled in the European Union und European Economic Area with a license to distribute / promote financial instruments in such capacity or herewith requesting respective information on products and services in their capacity as Professional Clients. 

The Funds are domiciled in Luxembourg and The Netherlands. ACOLIN Fund Services AG, postal address: Affolternstrasse 56, 8050 Zürich, acts as the Swiss representative of the Fund(s). UBS Switzerland AG, Bahnhofstrasse 45, 8001 Zurich, postal address: Europastrasse 2, P.O. Box, CH-8152 Opfikon, acts as the Swiss paying agent. The prospectus, the Key Investor Information Documents (KIIDs), the articles of association, the annual and semi-annual reports of the Fund(s) may be obtained, on simple request and free of charge, at the office of the Swiss representative ACOLIN Fund Services AG. The prospectuses are also available via the website www.robeco.ch. Some funds about which information is shown on these pages may fall outside the scope of the Swiss Collective Investment Schemes Act of 26 June 2006 (“CISA”) and therefore do not (need to) have a license from or registration with the Swiss Financial Market Supervisory Authority (FINMA). 

Some funds about which information is shown on this website may not be available in your domicile country. Please check the registration status in your respective domicile country. To view the RobecoSwitzerland Ltd. products that are registered/available in your country, please go to the respective Fund Selector, which can be found on this website and select your country of domicile. 

Neither information nor any opinion expressed on this website constitutes a solicitation, an offer or a recommendation to buy, sell or dispose of any investment, to engage in any other transaction or to provide any investment advice or service. An investment in a Robeco Switzerland Ltd. product should only be made after reading the related legal documents such as management regulations, prospectuses, annual and semi-annual reports. 

By clicking “I agree” you confirm that you/the company you represent falls under one of the above-mentioned categories of addressees and that you have read, understood and accept the terms of use for this website.

I Disagree